GuideCardiology
Heart failure risk after myocardial infarction (VALIANT)
Predictors of first heart failure hospitalisation in stable survivors of high-risk myocardial infarction (VALIANT trial).
Updated 3 November 2026
When to use it
Follow-up of patients without prior heart failure who survived a myocardial infarction complicated by pulmonary congestion or left ventricular dysfunction.
Warning
VALIANT predates current therapies (sacubitril/valsartan, SGLT2 inhibitors); current absolute risk may be lower.
What it is
Analysis of 11,040 stable VALIANT patients (myocardial infarction with pulmonary congestion or left ventricular dysfunction, no major events in the 45 days after randomisation and no prior heart failure) to identify who develops a first heart failure hospitalisation.
Keep reading in the app
- Predictors
- Key findings
- Practical use
Practical tip
Most heart failure cases occurred without a preceding reinfarction.
2 more practical tips in the app.
Reference
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
